2 March 2022
This follows the judge’s order for Pfizer to release these documents:
“The FDA shall produce the remaining documents at a rate of 55,000 pages every 30 days, with the first production being due on or before March 1, 2022, until production is complete.”
The document’s APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST (P30 – P38) contains a list of all recorded adverse events associated with Pfizer’s COVID-19 vaccine.
5.3.6-postmarketing-experience
Other Pfizer documents found here